RARE Past Earnings Q&A

On this page we presented the RARE past earnings date information for Ultragenyx Pharmaceutical. Reviewing that RARE Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2020, when RARE posted gaap of -0.370/share. Meanwhile the lowest RARE past earnings result was in Q3 2022, when RARE posted gaap of -2.430/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2023 when RARE reported 0.13B in revenue, while the smallest revenue quarter was Q2 2017 when RARE reported NA in revenue.

Any self directed investor doing their due diligence on RARE or any other given stock can benefit from researching all of the Ultragenyx Pharmaceutical past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Ultragenyx Pharmaceutical past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RARE. Thanks for visiting, and the next time you need to research RARE past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.